Quantifying risk of early relapse in patients with first demyelinating events: Prediction in clinical practice
Quantifying risk of early relapse in patients with first demyelinating events: Prediction in clinical practiceMultiple Sclerosis Journal, Volume 23, Issue 10, Page 1346-1357, September 2017. … read morePosted At: MS Journal
Apitope Announces Successful Completion of Second Phase I Trial of ATX-MS-1467, an Immune Therapy Wh
Apitope Announces Successful Completion of Second Phase I Trial of ATX-MS-1467, an Immune Therapy Wh/About-the-Society/News/Apitope-Announces-Successful … read morePosted At: National MS Society
Final 5-Year Results Published from Study of Bone Marrow Stem Cell Transplantation in Relapsing MS/About-the-Society/News/Final-5-Year-Results-Published-from-Study-of-Bone … read morePosted At: National MS Society
Italian Researchers Find that MS Disease-Modifying Therapies Reduce the Risk of Future MS Progressio
Italian Researchers Find that MS Disease-Modifying Therapies Reduce the Risk of Future MS Progressio/About-the-Society/News/Italian-Researchers-Find-that-MS-Disease-Modifying … read morePosted At: National MS Society
MS could be reversed with existing allergy drugAn over-the-counter allergy drug may restore function to the nerves damaged by multiple sclerosis, according to a recent phase II trial. … read morePosted At: Medical News...
- Next story Does Damage to Myelin-Producing Cells Trigger Nervous System Inflammation?
- Previous story New Study Reports Evidence that Vitamin D Plays a Role in Myelin Repair
Join Our Mailing List
- MS: Gut bacteria may trigger harmful mechanismPosted At: Medical News Today
- World’s Largest MS Research Conference: Understanding MS and New Strategies to Restore Function
- Conceptual framework to study role of exercise in multiple sclerosis
- Insights into microbiome research 3: Who’s there versus what are they doing?
- Updates From ECTRIMS Research Conference
- Environmental factors may trigger onset of multiple sclerosis
- Genetic Ancestry Associated with Clinical Course in Hispanic-Latinos: Study is Ongoing
- Prognostic information for people with MS: Impossible or inevitable?
- New immunotherapy targeting blood-clotting protein
- Animal models of multiple sclerosis: From rodents to zebrafish